HomeTopiramateTopiramate + Dapagliflozin And Metformin Hydrochloride

Does Topiramate Interact with Dapagliflozin And Metformin Hydrochloride?

Topiramate and Dapagliflozin And Metformin Hydrochloride have a major drug interaction according to U.S. FDA drug labeling data. Decreases serum bicarbonate and induces metabolic acidosis; concomitant use may increase risk for lactic acidosis. The mechanism involves carbonic anhydrase inhibition causing non-anion gap, hyperchloremic metabolic acidosis. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Topiramate Class
Cytochrome P450 3A4 Inducers
Dapagliflozin And Metformin Hydrochloride Class
Sodium-Glucose Cotransporter 2 Inhibitor
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Topiramate and Dapagliflozin And Metformin Hydrochloride occurs because carbonic anhydrase inhibition causing non-anion gap, hyperchloremic metabolic acidosis. Clinically, this means decreases serum bicarbonate and induces metabolic acidosis; concomitant use may increase risk for lactic acidosis. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Topiramate and your doctor is considering prescribing Dapagliflozin And Metformin Hydrochloride (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Topiramate(Qsymia)+💊 Dapagliflozin And Metformin Hydrochloride(Xigduo)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Cytochrome P450 3A4 Inducers
Drug B class
Sodium-Glucose Cotransporter 2 Inhibitor
Source
NLP:dapagliflozin and metformin hydrochloride

What this means in plain English

Decreases serum bicarbonate and induces metabolic acidosis; concomitant use may increase risk for lactic acidosis.

About Topiramate and Dapagliflozin And Metformin Hydrochloride

Topiramate is a Cytochrome P450 3A4 Inducers, while Dapagliflozin And Metformin Hydrochloride is a Sodium-Glucose Cotransporter 2 Inhibitor. You may recognize them by the brand names Qsymia and Xigduo. Both medications are taken by mouth. Dapagliflozin And Metformin Hydrochloride additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"Carbonic anhydrase inhibition causing non-anion gap, hyperchloremic metabolic acidosis"

📖 Source: NLP:dapagliflozin and metformin hydrochloride

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Topiramate and Dapagliflozin And Metformin Hydrochloride against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.